The Role of Treprostinil in the Management of Pulmonary Hypertension

By Skoro-Sajer Nika   Lang Irene  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 4, 2008-01 ,pp. : 213-217

Adis International

Access to resources Recommend Favorite

Treprostinil therapy for pulmonary artery hypertension

By Horn Evelyn M   Barst Robyn J  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 11, 2002-11 ,pp. : 1615-1622

Informa Healthcare

Access to resources Recommend Favorite

Inhaled treprostinil is an effective, well-tolerated add-on therapy for patients with pulmonary arterial hypertension (PAH) treated with bosentan

By  

Inpharma, Vol. 1, Iss. 1561, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Sitaxsentan sodium appears to be more cost effective than bosentan in treating patients with pulmonary arterial hypertension (PAH)

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 508, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Optimal Use of Treprostinil in Pulmonary Arterial Hypertension: A Guide to the Correct Use of Different Formulations

By Skoro-Sajer Nika  

Drugs, Vol. 72, Iss. 18, 2012-12 ,pp. : 2351-2363

Adis International

Access to resources Recommend Favorite